ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Xap Therapeutics Limited

Xap Therapeutics Limited is an active company incorporated on 10 February 2017 with the registered office located in Cambridge, Cambridgeshire. Xap Therapeutics Limited was registered 8 years ago.
Status
Active
Active since incorporation
Company No
10613866
Private limited company
Age
8 years
Incorporated 10 February 2017
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Confirmation
Submitted
Dated 9 February 2025 (10 months ago)
Next confirmation dated 9 February 2026
Due by 23 February 2026 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Address
Babraham Research Campus
Maia Building (B270)
Cambridge
CB22 3AT
United Kingdom
Address changed on 30 Aug 2022 (3 years ago)
Previous address was 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom
Telephone
1300657700
Email
Unreported
People
Officers
5
Shareholders
21
Controllers (PSC)
1
Director • Entrepreneur • Canadian • Lives in UK • Born in Feb 1970
Director • German • Lives in Switzerland • Born in Jun 1967
Director • Investment Professional • British • Lives in England • Born in Jul 1984
Director • Venture Capital • British,american • Lives in United States • Born in Mar 1977
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Econic Biosciences Limited
Shaun Patrick Foy, Mahesh Kudari, and 1 more are mutual people.
Active
SR One Capital Advisors Limited
Simeon John George is a mutual person.
Active
Ers Private Office Limited
Shaun Patrick Foy is a mutual person.
Active
Genelle Capital Ltd
Shaun Patrick Foy is a mutual person.
Active
Ers Genomics Limited
Shaun Patrick Foy is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2018–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£4.13M
Increased by £785K (+23%)
Turnover
£82K
Increased by £38K (+86%)
Employees
38
Increased by 6 (+19%)
Total Assets
£6.74M
Decreased by £623K (-8%)
Total Liabilities
-£21.5M
Increased by £10.38M (+93%)
Net Assets
-£14.76M
Decreased by £11M (+293%)
Debt Ratio (%)
319%
Increased by 167.86% (+111%)
Latest Activity
Group Accounts Submitted
1 Month Ago on 7 Nov 2025
Matthew Foy Resigned
4 Months Ago on 6 Aug 2025
Mr Mahesh Kudari Appointed
4 Months Ago on 6 Aug 2025
New Charge Registered
6 Months Ago on 10 Jun 2025
Confirmation Submitted
9 Months Ago on 22 Feb 2025
Group Accounts Submitted
1 Year 2 Months Ago on 8 Oct 2024
Shares Cancelled
1 Year 7 Months Ago on 26 Apr 2024
Own Shares Purchased
1 Year 7 Months Ago on 26 Apr 2024
Confirmation Submitted
1 Year 9 Months Ago on 23 Feb 2024
Bruce Goldsmith Resigned
1 Year 11 Months Ago on 14 Dec 2023
Get Credit Report
Discover Xap Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 7 October 2025
Submitted on 21 Nov 2025
Group of companies' accounts made up to 31 December 2024
Submitted on 7 Nov 2025
Statement of capital following an allotment of shares on 6 October 2025
Submitted on 20 Oct 2025
Appointment of Mr Mahesh Kudari as a director on 6 August 2025
Submitted on 11 Aug 2025
Termination of appointment of Matthew Foy as a director on 6 August 2025
Submitted on 11 Aug 2025
Statement of capital following an allotment of shares on 22 July 2025
Submitted on 31 Jul 2025
Statement of capital following an allotment of shares on 2 July 2025
Submitted on 30 Jul 2025
Statement of capital following an allotment of shares on 30 June 2025
Submitted on 30 Jul 2025
Statement of capital following an allotment of shares on 2 July 2025
Submitted on 30 Jul 2025
Resolutions
Submitted on 19 Jun 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year